Key Insights

Highlights

Treatment Research

2 treatments under study, led by Egd With Biopsy

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03282084WithdrawnPrimary

A Prospective, Observational Study of the PPI Non-responder

Showing all 1 trials

Research Network

Common Treatments

  • Egd With Biopsy1
  • Egd And Impedanceph Study On Ppi1

Active Sponsors

  • Dartmouth-Hitchcock Medical Center1

Top Investigators

Activity Timeline